Legal Framework of the Innovative Models of Medical Provision in Russia, France and Spain

Student: David Gor

Educational Programme: Pharmaceutical and Health Care Law (Master)

Year of Graduation: 2024

Legal regulation of innovative models of drug supply in Russia, France, and Spain plays an important role in ensuring accessibility and effectiveness of pharmaceuticals for patients. All three countries have different approaches to legal regulation, including risk-sharing agreements, Contrat de Bon Usage (CBU), and state pricing regulation programs for drugs. The aim of these measures is to stimulate innovation in the pharmaceutical industry and ensure accessibility of innovative drugs for patients. Further development and improvement in this area require joint efforts from governments, the pharmaceutical industry, and other stakeholders.

Student Theses at HSE must be completed in accordance with the University Rules and regulations specified by each educational programme.

Summaries of all theses must be published and made freely available on the HSE website.

The full text of a thesis can be published in open access on the HSE website only if the authoring student (copyright holder) agrees, or, if the thesis was written by a team of students, if all the co-authors (copyright holders) agree. After a thesis is published on the HSE website, it obtains the status of an online publication.

Student theses are objects of copyright and their use is subject to limitations in accordance with the Russian Federation’s law on intellectual property.

In the event that a thesis is quoted or otherwise used, reference to the author’s name and the source of quotation is required.

Search all student theses